Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mold Infection”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Early research (Phase 1)Study completedNCT02715570
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945

Who this might be right for
Aspergillosis
Pulmocide Ltd 29
Post-approval studies (Phase 4)Ended earlyNCT00620074
What this trial is testing

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Who this might be right for
Aspergillosis
Pfizer 6
Testing effectiveness (Phase 2)Looking for participantsNCT07215273
What this trial is testing

Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections

Who this might be right for
Suspected Invasive Mould Infection
Elion Therapeutics, Inc. 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Large-scale testing (Phase 3)Study completedNCT00634049
What this trial is testing

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Who this might be right for
AspergillosisInvasive Fungal Infections
Astellas Pharma Inc 149
Large-scale testing (Phase 3)Study completedNCT00412893
What this trial is testing

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Who this might be right for
AspergillosisInvasive Fungal Infection
Astellas Pharma Inc 527
Post-approval studies (Phase 4)Looking for participantsNCT07283497
What this trial is testing

Itraconazole Therapy In Bronchiectasis With Airway Mold

Who this might be right for
BronchiectasisFungal Infection of Upper Respiratory Tract
Mayo Clinic 30
Not applicableLooking for participantsNCT06498310
What this trial is testing

Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Who this might be right for
Invasive Fungal Infections
University Hospital, Strasbourg, France 100
Not applicableLooking for participantsNCT03827694
What this trial is testing

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Who this might be right for
Pulmonary Invasive Fungal InfectionsPulmonary Invasive Aspergillosis
Arkansas Children's Hospital Research Institute 400
Not applicableStudy completedNCT00437541
What this trial is testing

Housing, Insulation and Health Study

Who this might be right for
Respiratory IllnessAsthma
University of Otago 4,000
Testing effectiveness (Phase 2)Ended earlyNCT04240886
What this trial is testing

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 21
Not applicableLooking for participantsNCT01386437
What this trial is testing

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Who this might be right for
Chronic Mucocutaneous CandidiasisInvasive AspergillosisCARD9+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Post-approval studies (Phase 4)Study completedNCT01416025
What this trial is testing

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

Who this might be right for
Fungal Infection
Johns Hopkins University 29
Not applicableUnknownNCT04720144
What this trial is testing

Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)

Who this might be right for
Invasive Mold InfectionsBreakthrough Invasive Mold InfectionsHematologic Malignancy+1 more
Centre Hospitalier Universitaire Vaudois 300
Not applicableAvailableNCT06433128
What this trial is testing

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica
Post-approval studies (Phase 4)Study completedNCT05630976
What this trial is testing

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Who this might be right for
Invasive Fungal Disease
Pfizer 70
Not applicableStudy completedNCT02318524
What this trial is testing

Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients

Who this might be right for
COPDPulmonary Fungal DiseasesEnvironmental Exposure
University Hospital, Lille 65
Not applicableActive Not RecruitingNCT05774990
What this trial is testing

Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoblastic Leukemia
University of Southern Denmark 800
Not applicableStudy completedNCT02714504
What this trial is testing

Anti-mold Azole in the Prophylaxis for Invasive Fusariosis

Who this might be right for
FusariosisOnychomycosis
Universidade Federal do Rio de Janeiro 239
Not applicableStudy completedNCT03066011
What this trial is testing

Registry of Patients Treated With Systemic Mold-Active Triazoles

Who this might be right for
Invasive Fungal Infection
Astellas Pharma Global Development, Inc. 2,015
Load More Results